RxDoctor Payments Data

Kathryn Holloway, MD

Neurological Surgery · Richmond, VANPI 1366470072

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (52.5%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 99.2% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2024 at $8,525 and has fallen 77.8% since, to $1,894 in 2025.

$20,159in general payments, 2019–2025

Across 24 payments — averaging $839.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$20K
  • Insightec,inc$98
  • Neuropace, Inc.$61
$580,733in research payments, 2019–2025

Across 14 payments — averaging $41,481 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$581K

What the payments were for

  • Consulting fees$10,58553%
  • Speaking & faculty fees$7,50037%
  • Travel & lodging$1,5418%
  • Food & beverage$4522%
  • Education$810%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)21$20,000
Insightec,inc2$98
Neuropace, Inc.1$61

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,159 in reported general payments places this provider in the 85th percentile of 156 neurological surgery providers in Virginia.

See all neurological surgery providers in Virginia

Medicare billing

Part B allowed, 2024
$77,311
Medicare patients
107
Services billed
369

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin54$446
Chlorhexidine Gluconate55$227

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Richmond

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →